Sagimet Biosciences Inc
SGMT
NASDAQ
Biotechnology
$10.55
USD
+1.27 (+13.69%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $567.79M
Volume 2.7M
Price Target
$12.00 – $12.00
USD
The 1 analysts offering 1-year price forecasts have a max estimate of $12.00 and a min estimate of $12.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$12.00
-$22.3 vs prior
Implied Upside
+13.7%
-211.7% vs prior
Analyst Covering
1
-2 vs prior period
Consensus
Buy
Unchanged vs prior
Signal Quality
Consensus Freshness
25%
Many ratings are older - consensus may be less current
Analyst Agreement
High
Targets are closely clustered - analysts agree more than usual
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
1 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
1 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Jonathan Wolleben | JMP Securities | Buy | Maintained | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
EIKN
Eikon Therapeutics Inc
$11.05
▲ +7.0%
FDMT
4D Molecular Therapeutics Inc
$12.19
▲ +4.6%
PRME
Prime Medicine Inc
$3.09
▼ -2.5%
MDXG
MiMedx Group Inc
$4.27
▲ +1.7%
ARTV
Artiva Biotherapeutics Inc
$11.45
▲ +1.3%
CBIO
Crescent Biopharma Inc
$17.14
▲ +3.1%
ALT
Altimmune Inc
$2.94
▲ +2.1%
TECX
Tectonic Therapeutic Inc
$34.91
▲ +2.7%
ASMB
Assembly Biosciences Inc
$32.95
▲ +10.0%
NVCT
Nuvectis Pharma Inc
$18.96
▼ -1.4%